Evidence mapPaperPMID 38879678Full record

ArticleNature communications2024

Intra-islet α-cell Gs signaling promotes glucagon release.

Liu Liu, Kimberley El, Diptadip Dattaroy, Luiz F Barella, Yinghong Cui, Sarah M Gray, Carla Guedikian, Min Chen, Lee S Weinstein, Emily Knuth and 7 more

Erratum issuedAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Overview of the DREADDs chemogenetics and the patent landscape of their actuators.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Liu LiuMolecular Signaling Section, LBC, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 20892, USA. liu.liu@nih.gov.ORCID http://orcid.org/0000-0002-8751-7103
Kimberley ElDuke Molecular Physiology Institute, Duke University, Durham, NC, 27701, USA.ORCID http://orcid.org/0000-0002-5550-1684
Diptadip DattaroyMolecular Signaling Section, LBC, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 20892, USA.
Luiz F BarellaMolecular Signaling Section, LBC, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 20892, USA.ORCID http://orcid.org/0000-0003-2211-3842
Yinghong CuiMolecular Signaling Section, LBC, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 20892, USA.
Sarah M GrayDuke Molecular Physiology Institute, Duke University, Durham, NC, 27701, USA.
Carla GuedikianDuke Molecular Physiology Institute, Duke University, Durham, NC, 27701, USA.ORCID http://orcid.org/0009-0005-8499-3955
Min ChenMetabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 20892, USA.
Lee S WeinsteinMetabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 20892, USA.
Emily KnuthDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Erli JinDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Matthew J MerrinsDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Jeffrey RomanInstitute for Diabetes, Obesity and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Klaus H KaestnerInstitute for Diabetes, Obesity and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Nicolai DolibaInstitute for Diabetes, Obesity and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Jonathan E CampbellDuke Molecular Physiology Institute, Duke University, Durham, NC, 27701, USA.ORCID http://orcid.org/0000-0003-4358-6331
Jürgen WessMolecular Signaling Section, LBC, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 20892, USA. jurgenw@niddk.nih.gov.ORCID http://orcid.org/0000-0003-0818-1232

Funding

Univ of Pennsylvania Diabetes Endocrinology Res CTRP30DK019525 · UNIVERSITY OF PENNSYLVANIA · 1986 to 2025
$10.9M
Role of G protein-coupled receptors in regulating glucose and energy homeostasisZIADK075021 · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · 2025 to 2025
$2.1M
ENGINEERED GLUCOSE METABOLISM IN INSULIN-SECRETING CELLSR01DK046492 · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · 1993 to 2025
$1.5M
Engineered Glucose Metabolism in Insulin Secreting CellsR37DK046492 · DUKE UNIVERSITY · 2003 to 2005
$1.2M
Mitochondrial ADP privation: A unifying model for glucose-induced insulin secretion.R01DK127637 · YALE UNIVERSITY · 2025 to 2025
$685k
Metabolic Functions of Pyruvate Kinase M2 in Pancreatic Beta-cellsR01DK113103 · UNIVERSITY OF WISCONSIN-MADISON · 2025 to 2025
$485k
Role of the Gnas Gene in Metabolic RegulationZIADK043313 · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · 2025 to 2025
$182k
Role of Gs-alpha in central regulation of energy and glucose metabolismZIADK043315 · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · 2025 to 2025
$182k
Role of Gs-alpha in pancreatic islet cell growth and functionZIADK043318 · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · 2025 to 2025
$182k
Targeting alpha-cell GPCRs to stimulate glucagon and counter hypoglycemiaK01DK132461 · DUKE UNIVERSITY · 2025 to 2025
$106k
Regulation of alpha-cell glucagon secretion by mitochondrial anaplerosis-cataplerosisF31DK134171 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI Emily Knuth · 2024 to 2024
$18k
Metabolic regulation of islet hormone secretion in diabetesI01BX005113 · VA · WM S. MIDDLETON MEMORIAL VETERANS HOSP · 2022 to 2025
BLRD VA I01 BX005113Intramural NIH HHS ZIA DK075021NIDDK NIH HHS F31 DK134171NIDDK NIH HHS F32 DK121420NIDDK NIH HHS K01 DK132461NIDDK NIH HHS P30 DK019525NIDDK NIH HHS R01 DK046492NIDDK NIH HHS R01 DK113103NIDDK NIH HHS R01 DK123075NIDDK NIH HHS R01 DK125353NIDDK NIH HHS R01 DK127637NIDDK NIH HHS R21 DK075021NIDDK NIH HHS R37 DK046492
6 · The paper itself

Abstract

Glucagon, a hormone released from pancreatic α-cells, is critical for maintaining euglycemia and plays a key role in the pathophysiology of diabetes. To stimulate the development of new classes of therapeutic agents targeting glucagon release, key α-cell signaling pathways that regulate glucagon secretion need to be identified. Here, we focused on the potential importance of α-cell G

Indexed as

GlucagonGlucagon-Secreting CellsGTP-Binding Protein alpha Subunits, GsMice, KnockoutSignal TransductionAdenosineAnimalsIslets of LangerhansMaleMiceMice, Inbred C57BLReceptor, Adenosine A2AAdenosineGlucagonGTP-Binding Protein alpha Subunits, GsReceptor, Adenosine A2A

Identifiers

PMID38879678
PMCPMC11180188

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.